Waldron Private Wealth’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,113
Closed -$768K 499
2024
Q3
$768K Sell
7,113
-239
-3% -$26.1K 0.03% 193
2024
Q2
$798K Sell
7,352
-77
-1% -$9.08K 0.04% 177
2024
Q1
$982K Sell
7,429
-1,998
-21% -$250K 0.04% 167
2023
Q4
$1.15M Sell
9,427
-113
-1% -$12.6K 0.05% 141
2023
Q3
$1.07M Buy
9,540
+43
+0.5% +$5.46K 0.06% 145
2023
Q2
$1.39M Buy
9,497
+14
+0.1% +$1.9K 0.07% 120
2023
Q1
$1.23M Sell
9,483
-24
-0.3% -$3.01K 0.06% 146
2022
Q4
$996K Hold
9,507
0.06% 158
2022
Q3
$996K Buy
9,507
+394
+4% +$43.2K 0.06% 158
2022
Q2
$959K Sell
9,113
-28
-0.3% -$3.32K 0.05% 171
2022
Q1
$1.17M Sell
9,141
-233
-2% -$28.1K 0.06% 164
2021
Q4
$1.16M Buy
+9,374
New +$1.23M 0.06% 157

Other funds holding ZBH

Waldron Private Wealth's ZBH Position: Q4 2024 in Review

Waldron Private Wealth sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 7,113 shares — an estimated $768K sold.

Waldron Private Wealth first reported a position in ZBH in Q4 2021 and held it in 12 quarters. The position peaked at $1.39M in Q2 2023. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Waldron Private Wealth reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Waldron Private Wealth sold 7,113 Zimmer Biomet shares in Q4 2024, an estimated $768K.
  • Waldron Private Wealth first reported a position in Zimmer Biomet in Q4 2021 and held it in 12 quarters.
  • Waldron Private Wealth's Zimmer Biomet position peaked at $1.39M in Q2 2023.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Waldron Private Wealth's 13F filing for Q4 2024, filed 24 Jan 2025.